Horizon Investment Services, LLC Amgen Inc Transaction History

Horizon Investment Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $225,854 - $263,644	-1,266 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $56,513 - $63,711	-305 Reduced 19.41%	1,266 $262,000
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $47,158 - $52,968	-284 Reduced 15.31%	1,571 $290,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $4.47 Million - $5.22 Million	-26,374 Reduced 93.43%	1,855 $316,000
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $198,834 - $222,159	-1,178 Reduced 4.01%	28,229 $4.91 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $5,687 - $6,494	34 Added 0.12%	29,407 $5.48 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,373	29,373 $5.06 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Horizon Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Investment Services, LLC with notifications on news.